PharmaSGP Holding SE (PSG) — Cash Flow Reinvestment Rate
PharmaSGP Holding SE (PSG) has a Cash Flow Reinvestment Rate of 0.34x as of March 2025, reinvesting €1.42 Million (capex €708.00K plus investments €-708.00K) from operating cash flow of €4.22 Million. Check cash flow quality index of PharmaSGP Holding SE to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaSGP Holding SE Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for PharmaSGP Holding SE across 11 annual periods. Explore PharmaSGP Holding SE long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for PharmaSGP Holding SE (2014–2024)
Year-by-year capital reinvestment analysis for PharmaSGP Holding SE. For live market cap and broader valuation context, see PharmaSGP Holding SE market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | €2.94 Million | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.07x | €1.73 Million | €26.64 Million | €866.00K | ▲ +77.2% |
| 2022 | 0.04x | €907.00K | €24.71 Million | €120.00K | ▼ -99.5% |
| 2021 | 6.83x | €83.55 Million | €12.24 Million | €94.00K | ▲ +7906.1% |
| 2020 | 0.09x | €1.32 Million | €15.46 Million | €420.00K | ▲ +102.1% |
| 2019 | 0.04x | €744.00K | €17.63 Million | €420.00K | ▲ +29.8% |
| 2018 | 0.03x | €274.00K | €8.43 Million | €274.00K | ▼ -45.4% |
| 2017 | 0.06x | €848.00K | €14.25 Million | €397.00K | ▼ -98.6% |
| 2016 | 4.35x | €15.43 Million | €3.55 Million | €11.88 Million | ▲ +914.8% |
| 2015 | 0.43x | €4.54 Million | €10.59 Million | €4.26 Million | ▼ -35.7% |
| 2014 | 0.67x | €3.60 Million | €5.41 Million | €2.01 Million | — |